VPS26A and pancreatic adenocarcinoma: Diagnostic and prognostic analyses also demonstrated that VPS26A expression has great value in the diagnosis of PAAD, and the high expression of VPS26A is associated with the poor prognosis of PAAD patients (Figure 3).